<div class="container">

<table style="width: 100%;"><tr>
<td>ReturnMeanControl</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Gives true mean survival times for the control therapy.</h2>

<h3>Description</h3>

<p>Returns the mean survival times for the control given efficacy and toxicity dose probability vector, distribution family and linear relationship, effiacy, toxicity and survival.
</p>


<h3>Usage</h3>

<pre><code class="language-R">ReturnMeanControl(ProbC, betaC, Family, alpha)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>ProbC</code></td>
<td>
<p>Probability of efficacy and toxicity for the control therapy.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>betaC</code></td>
<td>
<p>Linear term for efficacy, toxicity and beta_0 for the control groupar term for efficacy, toxicity and beta_0 for the control group.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>Family</code></td>
<td>
<p>Time to event distribution. Options include: Exponential, Gamma, Weibull, Lognormal.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>
<p>Shape parameter or standard deviation of a lognormal distribution.</p>
</td>
</tr>
</table>
<h3>References</h3>

<p>[1] Chapple and Thall (2018).A Hybrid Phase I-II/III Clinical Trial Design Allowing Dose Re-Optimization in Phase III. Biometrics. In Press,
</p>


<h3>Examples</h3>

<pre><code class="language-R">###Family of Distributions
Family="Gamma"
###Shape parameter
alpha=2
##True beta vector for efficacy, toxicity and intercept of the control treatment
betaC=c(.3,-.25,2.389)
##True efficacy and toxicity probability for control group
ProbC = c(.4,.15)
ReturnMeanControl(ProbC,betaC,Family,alpha)
</code></pre>


</div>